Dose titration during anti-thymocyte globulin therapy: Monitoring by CD3 count or total lymphocyte count?

Clinical and Laboratory Haematology

Volumn 19, Issue 1, 1997, Pages 53-56

  Gorrie, M ^a   Thomson, G ^a   Lewis, D M ^a   Boyce, M ^a   Riad, H N ^a   Beaman, M ^a   Nicholls, A J ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

Anti lymphocyte serum; Cost analysis; Graft rejection; Kidney transplantation; T lymphocytes

Indexed keywords

CD3 ANTIGEN; LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY;

ARTICLE; CLINICAL ARTICLE; GRAFT REJECTION; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MONITORING; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030895538     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1997.00210.x     Document Type: Article

References (6)

1. Barry J.M. (1992) Immunosuppressive drugs in renal transplantation. A review of the regimens. Drugs 44, 554-566.
2. Clark K.R., Forsythe J.L., Shenton B.K., Lennard T.W., Proud G. & Taylor K.M. (1992) Flow-cytometric monitoring at ATG therapy for steroid-resistant rejection. Transplantation Proceedings 24, 305.
3. Clark K.R., Forsythe J.L., Shenton B.K. Lennard T.W., Proud G. & Taylor R.M. (1995) Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection. Transplant International 6, 18-21.
4. Kreis H. (1992) Antilymphocyte globulins in kidney transplantation. Kidney International Supplement 38, S188-192.
5. Morgan J.D., Horsburgh T., Simpson A., Donnelly P.K., Veitch P.S. & Bell P.R. (1992) Cytomegalovirus infection during OKT3 treatment for renal allograft rejection. Transplantation Proceedings 24, 2634-2635.
6. Stratta R.J., D'Alessandro A.M., Armbrust M.J. et al. (1989) Sequential antilymphocyte globulin/cyclosporine immunosupression in cadaveric renal transplantation. Effect of duration of ALG therapy. Transplantation 47, 96-102.